Cencora director receives 557-share stock award

Baumann Werner reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 03/09/2026 - 04:22 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Baumann Werner reported acquisition or exercise transactions in this Form 4 filing.

Cencora, Inc. director Werner Baumann received an annual equity award in the form of restricted stock units covering 557 shares of common stock at a reference price of $359.28 per share. The units were received for no cash consideration and will vest 100% on the first anniversary of the grant date. Following this grant, Baumann directly holds 3,687 shares of Cencora common stock.

Insider Trade Summary

Grant/Award: 557 shares

Grant/Award 1 txn

Insider Baumann Werner

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	557	$359.28	$200K

Holdings After Transaction: Common Stock — 3,687 shares (Direct)

Footnotes (1)

1. F1. Annual grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of grant.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Cencora (COR) report for Werner Baumann?

Cencora reported that director Werner Baumann acquired 557 shares of common stock through an annual grant of restricted stock units. These RSUs were received for no cash consideration and represent routine director compensation rather than an open-market purchase.

At what price was Werner Baumann’s Cencora (COR) stock award valued?

The 557 shares underlying Werner Baumann’s award were valued at $359.28 per share. This price is used as the reference value for reporting purposes and does not reflect an amount paid by Baumann, since the restricted stock units were received for no consideration.

How many Cencora (COR) shares does Werner Baumann hold after this Form 4 transaction?

After the reported grant, Werner Baumann directly holds 3,687 shares of Cencora common stock. This total includes the shares underlying the newly awarded restricted stock units, which are subject to vesting conditions over the specified period.

When do Werner Baumann’s newly granted Cencora (COR) restricted stock units vest?

The annual grant of restricted stock units to Werner Baumann vests 100% on the first anniversary of the grant date. Until vesting, the award is subject to the time-based condition described, typical for director equity compensation programs.

Did Werner Baumann pay cash for his new Cencora (COR) restricted stock units?

No, Werner Baumann did not pay cash for the new restricted stock units. The footnote explains that this was an annual grant of RSUs received for no consideration, reflecting standard non-cash equity compensation for serving as a director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Baumann Werner

(Last) (First) (Middle)

1 WEST FIRST AVENUE

(Street)

CONSHOHOCKEN PA 19428

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cencora, Inc. [ COR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/05/2026		A		557	A	$359.28	3,687(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Annual grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of grant.

Remarks:

	/s/ Elizabeth S. Campbell, attorney-in-fact for Werner Baumann	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.